Study: Aspirin May Not Save Lives newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.
Scientific American
Fighting the Quiet Crisis of Noncommunicable Diseases
COVID-19 has undermined capacity for care of patients with chronic, non-infectious diseases. Public-private partnerships aim to restore and improve.
This article was produced for Viatris by Scientific American Custom Media, a division separate from the magazine s board of editors. January 27, 2021
Improving care for heart disease, the most prevalent noncommunicable disease, could save millions of lives worldwide. Credit:
insta photos/Shutterstock
After years working in the U.K.’s National Health Service (NHS), Joanne Loades, an independent nurse and health educator from Norwich left in 2010 to pursue her own healthcare consulting business. Since then, Loades has set up programs, advised the NHS and trained more than 5,000 healthcare providers to encourage high-quality, evidence-based care for cardiovascular disease.
News | ECG | February 02, 2021
Cardiac Insight Speaks Out Against Medicare Decision to Slash Reimbursement Rates and Limit Access to New ECG Technologies
There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.
February 2, 2021 Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis, said a recent Medicare reimbursement rate reduction for long-term electrocardiogram (ECG) monitoring is a big set back for patient care.
The rates published by Medicare Administrative Contractor (MAC) Novitas Solutions for CPT codes 93241, 93243, 93245, and 93247 showed up to a 74% reduction in physician reimbursements, Cardiac Insight said.
High cholesterol increases the risk of heart disease, the leading cause of death in the United States, and stroke (the fifth most-common cause), according to the Centers for Disease Control and Prevention (CDC). So it’s no wonder that medical researchers have dedicated a great deal of energy to finding new and improved treatment options. We spoke to the experts to get their take on the most exciting breakthroughs in cholesterol treatment research, from historic drug developments to medications that may be just around the corner.
Statins: The Go-To Drug Treatment for Cholesterol
The first treatment for high cholesterol is typically a prescription for a healthy diet, weight loss, and exercise, says Randy Zusman, M.D., cardiologist and director of the division of hypertension at the Massachusetts General Hospital Heart Center in Boston, MA. But medications can play an important role in treatment as well especially when lifestyle changes simply aren’t cutting it. The medication doc
February 1, 2021
Three study authors to be recognized for abstract achievements at ACC Cardiovascular Summit
WASHINGTON (February 1, 2021) The American College of Cardiology has awarded three abstract awards to study authors for their posters presented at the Cardiovascular Summit Virtual. The award winners will be recognized at the Cardiovascular Summit, held virtually February 12-13, 2021. As the move toward value-based health care continues, it is critical that members of the cardiovascular community engage around quality improvement and cost reduction strategies. Posters sought to engage cardiovascular team members in the process of delivering value-based care; share practical
quality improvement and/or cost reduction strategies; encourage dissemination and implementation of evidence-based interventions that can be applied in clinical practice; and facilitate networking for those interested in value-based health care.